Morgan Stanley »

Inozyme Pharma shares owned by Morgan Stanley

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $111k 26k 4.20
2023-06-30 $187k 34k 5.57
2022-12-31 $14k 13k 1.03
2022-06-30 $217k 41k 5.26
2022-03-31 $65k 16k 4.07
2021-06-30 $688k 43k 16.09
2020-12-31 $406k 20k 20.64
2020-09-30 $33k 1.3k 26.38